5:52 PM
 | 
Feb 05, 2013
 |  BC Extra  |  Company News

Protalix jumps on exploration of strategic alternatives

Protalix BioTherapeutics Inc. (NYSE-M:PLX; Tel Aviv:PLX) jumped $0.79 (15%) to $6.15 on Tuesday after announcing that it engaged Citigroup to assist in exploring strategic alternatives including product partnering and technology sharing. At Sept....

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >